Scholarly publications and presentations by Rochester Regional Health's Research department authors.
Submissions from 2024
12-2-2024 Modeling conjugate vaccine and natural induced antibody correlates of protection for pneumococcal colonization and acute otitis media infection in young children, Minh Pham, Department of Decision Sciences, San Francisco State College, San Francisco, CA and College of Business and Management, Vin University, Hanoi, Viet Nam. and Michael Pichichero, Rochester Regional Health
11-16-2024 A Computational Pipeline for Identifying Gene Regulatory Networks: A Case Study of Response to Exercise, Nadia Moore, Rochester Regional Health, Jeffrey Page, Rochester Regional Health, William E. Kraus, et al.
11-16-2024 A Computational Protocol for the Knowledge-Based Assessment and Capture of Pathologies, Jeffrey Page, Rochester Regional Health; Nadia Moore, Rochester Regional Health; and Gordon Broderick, Rochester Regional Health
11-15-2024 Pneumococci Isolated From Children in Community-Based Practice Differ From Isolates Identified by Population- and Laboratory-Based Invasive Disease Surveillance, Ravinder Kaur, Rochester Regional Health, Ryan Gierke, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Lesley McGee, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., et al.
10-1-2024 Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media, Ravinder Kaur, Rochester Regional Health, Steven Schulz, Rochester Regional Health, Andrew Sherman, Rochester Regional Health, et al.
7-3-2024 Respiratory infection- and asthma-prone, low vaccine responder children demonstrate distinct mononuclear cell DNA methylation pathways, David Martino, Wal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia., Nikki Schultz, Wal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia., Ravinder Kaur, Rochester Regional Health, et al.
6-14-2024 Variability of Vaccine Responsiveness in Young Children, Michael Pichichero, Rochester Regional Health, Lei Xu, Rochester Regional Health, Eduardo Gonzalez, Rochester Regional Health, et al.
6-1-2024 Incorporating Regional Brain Connectivity Profiles into the Inference of Exposure-Related Neurobehavioral Burden in Explosive Ordnance Disposal Veterans, Jeffrey Page, Rochester Regional Health, Hyuk Oh, Thomas P. Chacko, Rochester Regional Health, et al.
6-1-2024 Mapping Signaling Mechanisms in Neurotoxic Injury from Sparsely Sampled Data Using a Constraint Satisfaction Framework, Jeffrey Page, Rochester Regional Health, Kimberly A. Kelly, Lindsay T. Michalovicz, et al.
5-9-2024 Reaction: Don’t hate the player in chemical AI; hate the game, Gordon Broderick, Rochester Regional Health
4-1-2024 Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines, Lei Xu, Rochester Regional Health; Peter Bajorski, School of Mathematical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.; and Brian Poligone, Rochester Regional Health
3-1-2024 Serotype 3 Antibody Response and Antibody Functionality Compared to Serotype 19A Following 13-Valent Pneumococcal Conjugate Immunization in Children, Naoko Fuji, Rochester Regional Health, Minh Pham, Department of Decision Sciences, Lam Family College of Business, San Francisco State University, San Francisco, California., Ravinder Kaur, Rochester Regional Health, et al.
Submissions from 2023
12-21-2023 Age-Stratified Investigation of Sleep Disorders and PTSD Prevalence Among Vietnam Veterans, Thomas Chacko, Rochester Regional Health, Sara Mithani, Melissa Bunker, et al.
12-21-2023 A Knowledge-Driven Bio-Behavioral Network Model of the Inflammasome and Caloric Restriction, Thomas Chacko, Rochester Regional Health, Gordon Broderick, Rochester Regional Health, Nadia Moore, Rochester Regional Health, et al.
12-1-2023 1688. Naturally-induced Serum Antibody Levels in Children to Pneumococcal Polysaccharide 15B that Correlate with Protection from Nasopharyngeal Colonization but Anti-serotype 15B Antibody has Low Functional Cross-reactivity with Serotype 15C, Ravinder Kaur, Rochester Regional Health, Eduardo Gonzalez, Rochester Regional Health, Minh Pham, et al.
12-1-2023 1725. Differences in serotype 3 antibody response and antibody functionality compared to serotype 19A following 13-valent pneumococcal conjugate immunization in children, Naoko Fuji, Rochester Regional Health, Minh Pham, Ravinder Kaur, Rochester Regional Health, et al.
12-1-2023 A stronger association of depression with rheumatoid arthritis in presence of obesity and hypertriglyceridemia, Grayden Shand, David D. Reh School of Business, Clarkson University, Potsdam, NY, United States., Daniel T. Fuller, Department of Mathematics, Clarkson University, Potsdam, NY, United States., Leon Lufkin, The Clarkson School, Clarkson University, Potsdam, NY, United States., et al.
11-22-2023 Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C, Ravinder Kaur, Rochester Regional Health, Eduardo Gonzalez, Rochester Regional Health, Minh Pham, et al.
11-1-2023 Liver Abscesses Due to Fusobacterium nucleatum: A Case Series, Ahmed Elkhapery, Rochester Regional Health, Sheza Malik, Rochester Regional Health, Pratibha Chaudhary, Rochester Regional Health, et al.
11-1-2023 Variability of vaccine responsiveness in early life, Michael E. Pichichero, Rochester Regional Health
10-27-2023 A regulatory pathway model of neuropsychological disruption in Havana syndrome, Thomas P. Chacko, Rochester Regional Health, J Tory Toole, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, et al.
10-26-2023 Very early life microbiome and metabolome correlates with primary vaccination variability in children, Michael Shaffer, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Katharine Best, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Catherine Tang, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., et al.
8-1-2023 Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections, Ravinder Kaur, Rochester Regional Health, Jill Mangiafesto, Rochester Regional Health, Karin Pryharski, Rochester Regional Health, et al.
4-18-2023 Colonization, Density, and Antibiotic Resistance of Streptococcus pneumoniae, Haemophilus Influenzae, and Moraxella catarrhalis among PCV13-Vaccinated Infants in the First Six Months of Life in Rochester, New York: A Cohort Study, Ravinder Kaur, Rochester Regional Health and Michael Pichichero, Rochester Regional Health
2-1-2023 Vaccine target and carrier molecule nontypeable Haemophilus influenzae protein D dimerizes like the close Escherichia coli GlpQ homolog but unlike other known homolog dimers, Seth P. Jones, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Kali H. Cook, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Melody L. Holmquist, National Technical Institute for the Deaf, Rochester Institute of Technology, Rochester, New York, USA., et al.